These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418 [TBL] [Abstract][Full Text] [Related]
31. Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells. Fiscus RR Neurosignals; 2002; 11(4):175-90. PubMed ID: 12393944 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model. du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294 [TBL] [Abstract][Full Text] [Related]
33. Activation of the small GTPase Rac1 by cGMP-dependent protein kinase. Hou Y; Ye RD; Browning DD Cell Signal; 2004 Sep; 16(9):1061-9. PubMed ID: 15212766 [TBL] [Abstract][Full Text] [Related]
34. Nitric-oxide-dependent activation of pig oocytes: the role of the cGMP-signalling pathway. Petr J; Rajmon R; Chmelíková E; Tománek M; Lánská V; Pribánová M; Jílek F Zygote; 2006 Feb; 14(1):9-16. PubMed ID: 16700970 [TBL] [Abstract][Full Text] [Related]
35. The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK. Frigolet ME; Thomas G; Beard K; Lu H; Liu L; Fantus IG Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E321-E334. PubMed ID: 28679626 [TBL] [Abstract][Full Text] [Related]
36. Interlude of cGMP and cGMP/protein kinase G type 1 in pancreatic adenocarcinoma cells. Karakhanova S; Golovastova M; Philippov PP; Werner J; Bazhin AV Pancreas; 2014 Jul; 43(5):784-94. PubMed ID: 24826884 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes. Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205 [TBL] [Abstract][Full Text] [Related]
38. The action of nitric oxide to enhance cell survival in chick cardiomyocytes is mediated through a cGMP and ERK1/2 pathway while p38 mitogen-activated protein kinase-dependent pathways do not alter cell death. Rabkin SW; Tsang MY Exp Physiol; 2008 Jul; 93(7):834-42. PubMed ID: 18344257 [TBL] [Abstract][Full Text] [Related]
39. Interaction between nitric oxide signaling and gap junctions during ischemic preconditioning: Importance of S-nitrosylation vs. protein kinase G activation. Xie F; Rong B; Wang TC; Hao L; Lin MJ; Zhong JQ Nitric Oxide; 2017 May; 65():37-42. PubMed ID: 28216239 [TBL] [Abstract][Full Text] [Related]
40. Nitric oxide and protein kinase G act on TRPC1 to inhibit 11,12-EET-induced vascular relaxation. Zhang P; Ma Y; Wang Y; Ma X; Huang Y; Li RA; Wan S; Yao X Cardiovasc Res; 2014 Oct; 104(1):138-46. PubMed ID: 25139746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]